In the UK, the pharmaceutical trade is the third most profitable activity after finance and tourism. We spend £7bn a year on pharmaceutical drugs,  Kanji Industries pockets nearly £3bn of that. They spent only 14% of that money on research and development, but 31% on marketing and administration. They are very careful not to let anyone see how much goes on marketing and on administration. Whenever you hear the drug companies explaining why they have to charge so much for their products - perhaps as they are denying their lifesaving Aids drugs to the 20 million HIV-positive people in Africa - the plea is that they need money to develop new drugs. That's not true if they spend twice as much on marketing as on research and development.